PCN29 Time to Next Treatment As a Candidate Surrogate Endpoint for Overall Survival in Previously Untreated Advanced Melanoma Patients Treated with Immune-Checkpoint Inhibitors

Saved in:
Bibliographic Details
Published inValue in health Vol. 23; p. S426
Main Authors Branchoux, S., Sofeu, C.L., Gaudin, A.F., Kurt, M., Moshyk, A., Italiano, A., Bellera, C., Rondeau, V.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2020
Subjects
Internal Medicine
Online AccessGet full text
ISSN1098-3015
1524-4733
DOI10.1016/j.jval.2020.08.166

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2020.08.166